Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses

Por Del Rosso, James Q., Sofen, Howard, Leshin, Barry, Meng, Tc, Kulp, James, Levy, Sharon
Publicado em 2009

Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

Por Adsit, Sandra, Zaldivar, Enrique Rivas, Sofen, Howard, Dei-Cas, Ignacio, Maldonado-García, César, Peñaranda, Elkin O., Puig, Luís, Meng, Xiangyi, Fox, Todd, Guana, Adriana
Publicado no Adv Ther (2017)

Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

Por Adsit, Sandra, Zaldivar, Enrique Rivas, Sofen, Howard, Dei-Cas, Ignacio, Maldonado-García, César, Peñaranda, Elkin O., Puig, Luís, Meng, Xiangyi, Fox, Todd, Guana, Adriana
Publicado no Adv Ther (2017)

Genomic analysis of Smoothened inhibitor resistance in basal cell carcinoma

Por Sharpe, Hayley J., Pau, Gregoire, Dijkgraaf, Gerrit J., Basset-Seguin, Nicole, Modrusan, Zora, Januario, Thomas, Tsui, Vickie, Durham, Alison B., Dlugosz, Andrzej A., Haverty, Peter M., Bourgon, Richard, Tang, Jean Y., Sarin, Kavita Y., Dirix, Luc, Fisher, David C., Rudin, Charles M., Sofen, Howard, Migden, Michael R., Yauch, Robert L., de Sauvage, Frederic J.
Publicado no Cancer Cell (2015)